{"id":"https://openalex.org/A5011558041","orcid":null,"observed_orcids":[],"display_name":"Ge He","raw_author_names":["Ge He"],"full_name":"Ge He","works_count":4,"cited_by_count":48,"summary_stats":{"2yr_mean_citedness":15.0,"h_index":4,"i10_index":2},"ids":{"openalex":"https://openalex.org/A5011558041","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I253932293","ror":"https://ror.org/0139j4p80","display_name":"Anhui University of Traditional Chinese Medicine","country_code":"CN","type":"education","lineage":["https://openalex.org/I253932293"]},"years":[2024,2022]}],"last_known_institutions":[{"id":"https://openalex.org/I253932293","ror":"https://ror.org/0139j4p80","display_name":"Anhui University of Traditional Chinese Medicine","country_code":"CN","type":"education","lineage":["https://openalex.org/I253932293"]}],"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","count":4,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","count":3,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","count":1,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","count":1,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","count":1,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","value":6.32e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","value":1.69e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","value":1.12e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12257","display_name":"Bioactive natural compounds","value":8.8e-06,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","value":8.1e-06,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.9282028675079346},{"id":"109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","score":0.5429033041000366},{"id":"202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","score":0.4017393887042999},{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.157878577709198},{"id":"104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","score":0.08449900150299072}],"counts_by_year":[{"year":2022,"works_count":3,"oa_works_count":0,"cited_by_count":1},{"year":2023,"works_count":0,"oa_works_count":0,"cited_by_count":4},{"year":2024,"works_count":1,"oa_works_count":0,"cited_by_count":9},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":17},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":17}],"display_name_alternatives":["Ge He"],"block_key":"g he","works_api_url":"https://api.openalex.org/works?filter=author.id:A5011558041","updated_date":"2026-11-06T12:48:51","created_date":"2022-07-01T00:00:00"}